rs142391704
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS1
The NM_000208.4(INSR):c.2117C>A(p.Ala706Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,613,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000208.4 missense
Scores
Clinical Significance
Conservation
Publications
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.2117C>A | p.Ala706Asp | missense_variant | Exon 10 of 22 | ENST00000302850.10 | NP_000199.2 | |
| INSR | NM_001079817.3 | c.2117C>A | p.Ala706Asp | missense_variant | Exon 10 of 21 | NP_001073285.1 | ||
| INSR | XM_011527988.3 | c.2117C>A | p.Ala706Asp | missense_variant | Exon 10 of 22 | XP_011526290.2 | ||
| INSR | XM_011527989.4 | c.2117C>A | p.Ala706Asp | missense_variant | Exon 10 of 21 | XP_011526291.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | c.2117C>A | p.Ala706Asp | missense_variant | Exon 10 of 22 | 1 | NM_000208.4 | ENSP00000303830.4 | ||
| INSR | ENST00000341500.9 | c.2117C>A | p.Ala706Asp | missense_variant | Exon 10 of 21 | 1 | ENSP00000342838.4 | |||
| INSR | ENST00000598216.1 | n.2092C>A | non_coding_transcript_exon_variant | Exon 10 of 10 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152038Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000111 AC: 28AN: 251392 AF XY: 0.000125 show subpopulations
GnomAD4 exome AF: 0.000285 AC: 417AN: 1461252Hom.: 0 Cov.: 32 AF XY: 0.000275 AC XY: 200AN XY: 726962 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152038Hom.: 0 Cov.: 31 AF XY: 0.0000943 AC XY: 7AN XY: 74248 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Insulin-resistant diabetes mellitus AND acanthosis nigricans Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Rabson-Mendenhall syndrome Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Leprechaunism syndrome Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at